 Connection
Mary Sammel to Pregnanediol
This is a "connection" page, showing publications Mary Sammel has written about Pregnanediol.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.473 |
|
|
|
-
Winkles JF, Colvin A, El Khoudary SR, Santoro N, Sammel M, Crawford S. Using a Composite Summary of Daily Sex Hormones to Gauge Time Until Menopause: A Focus on Pregnanediol Glucuronide (PDG). J Clin Endocrinol Metab. 2025 Sep 16; 110(10):2832-2844.
Score: 0.231
-
Johnson L, Sammel MD, Schanne A, Lechtenberg L, Prewitt M, Gracia C. Female cancer survivors exposed to alkylating-agent chemotherapy have unique reproductive hormone profiles. Fertil Steril. 2016 Dec; 106(7):1793-1799.e2.
Score: 0.124
-
Winkles JF, Santoro N, El Khoudary SR, deSouza P, Matuk J, Crawford S, Colvin A, Sammel M, Park SK. Associations between pollutants, the regularity of daily sex hormone patterns, and hormone profiles over a complete menstrual cycle. Reprod Toxicol. 2026 Aug; 143:109247.
Score: 0.060
-
Winkles JF, Santoro N, Sammel MD, El Khoudary SR, Colvin A, Crawford S. Measuring associations between hormonal entropy, the prevalence of vasomotor symptoms, and menstrual dynamics. Am J Physiol Endocrinol Metab. 2025 11 01; 329(5):E603-E615.
Score: 0.058
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|